Two researchers from Indiana University School of Medicine spoke with the hosts of the daVinci Pursuit podcast about the IU Precision Health Initiative and their breast cancer research.
Bryan P. Schneider, MD, and Milan Radovich, PhD, discussed their groundbreaking discovery towards the treatment of triple negative breast cancer. Schneider and Radovich are co-leaders of the IU Precision Health Initiative triple negative breast cancer disease research team.
"Triple negative breast cancer accounts for about 20 percent of the patients who have breast cancer," said Schneider. "It's important because it affects young women, and especially African American women."
Nadia Miller, who is the board president of Pink-4-Ever, an Indianapolis-based, minority-focused breast cancer awareness and outreach organization, also joined them on the podcast.